Clinical Trials Logo
NCT number NCT03497182
Study type Interventional
Source Landon Pediatric Foundation
Contact Chris Landon, MD
Phone 805-652-6075
Email chris.landon@ventura.org
Status Recruiting
Phase N/A
Start date May 2, 2017
Completion date October 31, 2018

Clinical Trial Summary

Breath samples will be collected from patients suspected of sepsis/severe sepsis or septic shock according to hospital sepsis screening criteria in the Emergency Department.


Clinical Trial Description

Breath samples will be collected from patients suspected of sepsis that meet the criteria in the hospital's Sepsis Patient Management Protocol for blood lactate point of care testing. The breath samples will be collected from the patient by the Respiratory Therapist (RT) at the time of blood sample collection for the blood lactate test.

The breath samples will be analyzed via gas chromatography-surface acoustic wave spectroscopy for detection of a pattern of volatile organic compounds (VOCs). Multivariate analysis will be performed on breath sample data to determine feasibility of associating a unique VOC pattern with septic/severe septic/septic shock patients.


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Recruiting NCT02714595 - Study of S-649266 or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Recruiting NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Enrolling by invitation NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT03167788 - Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery Phase 2
Not yet recruiting NCT03213990 - Beta-Lactam InfusioN Group Study N/A
Recruiting NCT02899143 - Short-course Antimicrobial Therapy in Sepsis Phase 2
Recruiting NCT02837731 - Fluid Responsiveness Evaluation in Sepsis-associated Hypotension Phase 4
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Recruiting NCT02930070 - qSOFA in General Wards: the Accuracy in Diagnosis of Sepsis N/A
Not yet recruiting NCT02907931 - Carotid VTI as a Measure of Intravascular Volume Status During Lower Body Negative Pressure Simulation N/A
Recruiting NCT02567305 - Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063) N/A
Recruiting NCT02565251 - Volemic Resuscitation in Sepsis and Septic Shock N/A
Completed NCT02467023 - Project 4B: Lower Extremity Strength Training in ICU Patients N/A
Recruiting NCT02210169 - RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates N/A
Recruiting NCT02914756 - HMGB1 in ICU-survivors N/A
Completed NCT02883218 - Observational Study to Understand the Impact of Community-acquired Sepsis Patients'Immunosuppression in Early Stage to Prognosis N/A
Completed NCT02079402 - Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Phase 4
Completed NCT02400697 - Placental Transfusion Project for Preterm Infants N/A
Recruiting NCT02544490 - Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis N/A